Free Trial

Cubist Systematic Strategies LLC Reduces Holdings in SunOpta Inc. (NASDAQ:STKL)

SunOpta logo with Consumer Staples background

Cubist Systematic Strategies LLC reduced its stake in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY by 95.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,900 shares of the company's stock after selling 107,258 shares during the quarter. Cubist Systematic Strategies LLC's holdings in SunOpta were worth $38,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Quarry LP purchased a new position in shares of SunOpta in the 4th quarter valued at approximately $36,000. D.A. Davidson & CO. purchased a new position in SunOpta during the 4th quarter worth approximately $81,000. Bayesian Capital Management LP raised its position in SunOpta by 15.2% during the 4th quarter. Bayesian Capital Management LP now owns 11,536 shares of the company's stock worth $89,000 after buying an additional 1,523 shares during the last quarter. Mutual Advisors LLC purchased a new position in SunOpta during the 4th quarter worth approximately $92,000. Finally, Quadrant Capital Group LLC raised its position in SunOpta by 15.2% during the 4th quarter. Quadrant Capital Group LLC now owns 14,542 shares of the company's stock worth $112,000 after buying an additional 1,923 shares during the last quarter. 85.39% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at SunOpta

In related news, SVP Bryan P. Clark sold 8,500 shares of SunOpta stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $5.32, for a total value of $45,220.00. Following the sale, the senior vice president now owns 28,150 shares of the company's stock, valued at approximately $149,758. This trade represents a 23.19% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.90% of the stock is owned by corporate insiders.

SunOpta Price Performance

NASDAQ:STKL opened at $6.35 on Tuesday. The company has a debt-to-equity ratio of 1.61, a current ratio of 1.20 and a quick ratio of 0.53. The firm has a market cap of $746.39 million, a price-to-earnings ratio of -35.28 and a beta of 1.50. The company has a 50 day moving average price of $4.77 and a 200-day moving average price of $6.44. SunOpta Inc. has a 1-year low of $3.65 and a 1-year high of $8.11.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.02 by $0.02. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%. The firm had revenue of $201.63 million for the quarter, compared to analysts' expectations of $195.09 million. Equities research analysts forecast that SunOpta Inc. will post 0.13 EPS for the current year.

Analyst Ratings Changes

Separately, StockNews.com raised shares of SunOpta from a "sell" rating to a "hold" rating in a report on Tuesday, March 11th.

Check Out Our Latest Stock Report on STKL

SunOpta Company Profile

(Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

See Also

Institutional Ownership by Quarter for SunOpta (NASDAQ:STKL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SunOpta Right Now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines